Amarin

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.35-$1.11
Market Cap
$192.3M
Shares Short
17M

Financials

See more
Revenue (12 Mos)
$228.6M
Revenue Growth (YoY)
-16.6%
Gross Profit (12 Mos)
$117.8M
Diluted EPS
-$0.20

News

See more

Yahoo Finance • 7 days ago

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

Yahoo Finance • 14 days ago

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program

Yahoo Finance • 27 days ago

Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering

Yahoo Finance • last month

Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025

About

CEO
Mr. Aaron D. Berg
Address
Iconic Offices, The Greenway, Dublin, Ireland, 112-114
Sector
Healthcare
Industry
Drug Manufacturers - General
Full-Time Employees
275